Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Actafarma is a Spanish pharmaceutical company specializing in the development and commercialization of self-care products, nutraceuticals, and dermocosmetics. Founded in 1997 and headquartered in Madrid, the company focuses on the concept of prevention through nutrition to improve quality of life and promote healthy aging. Its portfolio includes market-leading brands such as Revidox for anti-aging, Oxicol for cholesterol management, and Movial for joint health. In 2017, Actafarma was acquired by Kern Pharma, a member of the Indukern Group, to strengthen its position in the consumer health and pharmacy channels. The company is recognized for its collaboration with scientific institutions, such as the Spanish National Research Council (CSIC), to validate the efficacy of its natural ingredients. Today, it continues to operate as a key player in the Spanish healthcare market with an expanding international presence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratorios Acta Farma.